top of page

MILLER ECO​NOMICS

Payer Matters in Development | Dossiers | Market

In Development

  • Odomzo® (Sun Pharma) - BCC
  • Lorbrena® (Pfizer) - NSCLC
  • Vizimpro® (Pfizer) - NSCLC
  • Kisqali® (Novartis) - aBC
  • Piqray® (Novartis) - aBC
  • Darzalex® (Janssen) - MM
  • Resiquimod® (Galderma) - CTCL
  • Nerlynx® (Puma) - aBC
  • Olumiant® (Lilly) - RA
  • Etrasimod® (Arena) - UC
  • Sunosi® (Jazz) - EDS
  • Bempedoic Acid (D-S) - CV
  • Abicipar® (Allergan) - wAMD
original?tenant=vbu-digital

In Dossiers

  • Erleada® (Janssen) - nmCRPC
  • Venclexta® (AbbVie) - CLL
  • Xospata® (Astellas) - AML
  • Bavencio® (Pfizer/Merck) - aRCC
  • Lynparza® (AZ) - aOC
  • Imfinzi® (AZ) - NSCLC
  • Tagrisso® (AZ) - NSCLC
  • Polivy® (Roche) - DLBCL
  • Jorveza® (Dr Falk) - GI
  • Rinvoq® (AbbVie) - RA
  • Veltassa® (Vifor) - hyperkalemia
  • Alofisel® (Takeda) - CD
  • Crysvita® (KKI) - XLH
original?tenant=vbu-digital

In Market

  • Zolgensma® (AveXis) - SMA
  • Dupixent® (Sanofi) - AD, +
  • Penthrox® (Galen) - trauma pain
  • Airsonett® Air (Airsonett) - allergic asthma, eczema [device]
  • Innovative contracting (Vertex)


original?tenant=vbu-digital
bottom of page